results of retrospective observational study of adalimumab safety and efficacy in patients with juvenile arthritis and uveitis

Clicks: 194
ID: 212098
2011
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract

The article contains results of retrospective observational study of adalimumab safety and efficacy in 67 juvenile arthritis and juvenile arthritis with eye involvement patients refractory to classical immunosuppressive treatment. It also contains a description of a recombinant biological medication ā€” adalimumab: already on the 4th week of treatment acute inflammatory changes in the affected joints were relieved, joint motion range fully recovered; by the week 8 ā€” full remission of the uveitis was reported in 45% of affected eyes (27/61), normalized disease activity lab parameters such as ESR, serum C-reactive protein.

Key words: children, juvenile rheumatoid arthritis, rheumatoid uveitis, adalimumab.
(Voprosy sovremennoi pediatrii ā€”Ā Current Pediatrics. ā€” 2011; 10 (6): 96ā€“102)

Reference Key
alexeeva2011voprosyresults Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Š•.I. Alexeeva;Š•.V. Mitenko;Š¢.Šœ. Bzarova;S.I. Valieva;Š.Šœ. Chomakhidze;K.B. Isaeva;Š•.G. Chistyakova;R.V. Denisova;T.V. Sleptsova;Š¢.Yu. Polyaeva;Š.N. Fetisova
Journal Biocontrol science
Year 2011
DOI DOI not found
URL
http://vsp.spr-journal.ru:80/jour/article/view/782
Keywords
efficacy Children quality of life methotrexate juvenile idiopathic arthritis safetypediatrics

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.